期刊文献+

MMP-9、TIMP-1在子宫内膜异位症患者子宫内膜中的表达及意义 被引量:6

Expression and significance of MMP-9 and TIMP-1 in endometriosis
下载PDF
导出
摘要 目的观察基质金属蛋白酶-9(MM P-9)和基质金属蛋白酶组织抑制剂-1(T IM P-1)在子宫内膜异位症(EM s)患者子宫内膜中的表达,并探讨其在EM s发病机制中的作用。方法利用免疫组化法检测MM P-9和T IM P-1在35例EM s患者(观察组,其中未孕16例、已孕19例)异位内膜及在位内膜组织和35例正常人(对照组)子宫内膜中的表达。结果①MM P-9在观察组异位内膜中的表达高于在位内膜和对照组(P均<0.05),在位内膜中的表达高于对照组(P均<0.05);②T IM P-1、MM P-9/T IM P-1在观察组异位内膜中的表达低于在位内膜和对照组(P均<0.05);观察组未孕与已孕患者MM P-9和T IM P-1表达以及MM P-9/T IM P-1均无统计学差异(P均>0.05)。结论MM P-9高表达以及MM P-9/T IM P-1的比例失调,使子宫内膜更具侵袭性,在EM s的发生、发展中起重要作用。 [Objective] To observe the expression of matrix metalloproteinases-9 (MMP-9) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) in endometriosis, and study the possible role of MMP-9 and TIMP-1 in the pathogenesis of endometriosis. Methods: Expression of MMP-9 and TIMP-1 in 35 normal endometrium as well as 35 ectopic endometrium and eutopic endometrium in endometriosis (16 nonfertile patients and 19 patients who had been pregnant) were detected by immunohistochemistry and the results were analyzed with SPSS11. 0 statistical solfware. [Results] ①The expression level of MMP-9 in the ectopic endometriotic tissues was significantly higher than those in the eutopic endometrium and normal endometrium (P both 0. 05). ②Theexpression level of TIMP-1 in the ectopic endometriotic tissues was significantly lower than those in the eutopic endometrium and normal endometrium (P〈0. 05). ③The gray scale ratio of MMP-9/TIMP-1 in the ectopic endometriotic tissues was significantly lower than those in the eutopic endometrium and normal endometrium (P〈0. 05). ④In the eetopic and eutopic endometriotic tissues and normal endometrium, there had no statistical difference between the nonfertile patients and the patients who had been pregnant in the expression level of MMP-9 and TIMP-1 and the gray scale ratio of MMP-9/TIMP-1 (P〉0. 05). [Conclusion]: The excessive expression of MMP-9 in ectopic endometriotic tissues and the disproportion of MMP-9/TIMP-1 makes the ectopic endometriotic tissues to have more invasive ability, which contributes to the pathogenesis of endometriosis.
作者 沈蓉 田永杰
机构地区 山东省立医院
出处 《山东医药》 CAS 北大核心 2006年第17期20-22,共3页 Shandong Medical Journal
基金 山东省自然科学基金项目(Y2003C01)
关键词 基质金属蛋白酶-9 基质金属蛋白酶组织抑制剂-1 子宫内膜异位症 免疫组织化学 matrix metalloproteinases-9(MMP-9) tissue inhibitors of matrix metalloproteinases-1(TIMP-1) endometriosis immunohistochemistry
  • 相关文献

参考文献7

  • 1郎景和.子宫内膜异位症的研究与设想[J].中华妇产科杂志,2003,38(8):478-480. 被引量:527
  • 2Seli E,Berkkanoglu M,Arici A.Pathogenesis of endometriosis[J].Obstet Gynecol Clin North Am,2003,30(1):41-61.
  • 3Matalliotakis IM,Goumenou AG,Reteval,et al.Serum concentrations of growth factors in women with and without endometriosis:the action of anti-endometriosis medicines[J].Int Immunopharmacol,2003,3 (1):81-89.
  • 4Gescher DM,haensel A,Meyhofer-Malik A,et al.The importance of angiogenesis for the pathogenesis of endometriosis[J].Zentralbl Gynakol,2003,125:243-246.
  • 5Chung H W,Wen Y,Chun S H,et al.Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis:a ration for endometriotic invasiveness[J].Fertril Steril,2001,75(1):152-159.
  • 6Hofmann UB,Westphal JR,Van Kraats AA,et al.Expression of integrin alpha (v) beta (3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT-MMP1) and matrix metalloproteinase-2(MMP-2)in human melanoma cells in vitro and in vivo[J].Int J Cancer,2000,87(1):12-19.
  • 7周小会,李兆艾.基质金属蛋白酶及其抑制物与子宫内膜异位症[J].中国药物与临床,2004,4(4):291-293. 被引量:2

二级参考文献19

  • 1[2]Matrisian LM.Metalloproteinases and their inhibitors in matrixremodeling.Trends Genet,1990,6:121-125.
  • 2[3]Spuijbroek MDEH,Dunselman GAJ,Menheere PPCA,et al.Earlyendometriosis invades the extracellular matrix.Fertil Steril,1992,58(5):929-933.
  • 3[4]Stetler-Sterenson WG.Dynamics of matrix during pathologic remodelling of the extracellular matrix.Am J Pathol,1996,148:1345-1350.
  • 4[5]Woessner JF.Matrix metalloproteinases and their inhibitors inconnective tissue remodeling.FASEB J,1991,5:2145-2154.
  • 5[6]Koks CA,Groothuis PG,Slsats P,et al.Matrix metalloproteinasesand their tissue inhibitors in antegradely shed menstruum andperitoneal fluid.Fertil Steril,2000,73(3):604-611.
  • 6[7]Rodergers WH,Matrisian LM,Giudice LC,et al.Patterns of matrixmetolloproteinase expression in cycling endometrium imply differential functions and regulation by steroids.J Clin Invest,1994,94(9):946-953.
  • 7[8]Mizumoto H,Saito T,Ashihara K,et al.Expression of matrix metalloproteinases in ovarian endometriomas:immunohistochemicalstudy and enzyme immunoassay.Life Sci,2002,71(3):259-273.
  • 8[9]Kokorine I,Eeckhout Y,Nisolle M,et al.Expression of interstitialcollagenase (matrix metalloproteinase-1) is related to the activityof human endometriotic lesions.Fertil Steril,1997,68(2):246-251.
  • 9[10]Wenzl RJ,Heinzl H.Localization of matrix metalloproteinase-2 inuterine endometrium and ectopic implant.Gynecol Obstet Invest,1998,45(4):253-257.
  • 10[11]Chung HW,Wen Y,Chun SH,et al.Matrix metalloproteinase-9 andtissue inhibitor of metalloprotinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis:a rationale for endometriotic invasiveness.Fertil Steril,2001,75 (1):152-159.

共引文献527

同被引文献50

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部